Table 2.
lncRNAs significantly associated with outcomes in non-ccRCC.
| Reference | lncRNA | Expression Level | Endpoint | Outcome | Independent in Multivariate Analysis |
|---|---|---|---|---|---|
| PapillaryRCC | |||||
| Lan et al., 2017 [134] | AFAP1-AS1 | ↑ | OS | poor | N/E * |
| GAS6-AS1 | ↓ | OS | poor | N/E * | |
| RP11-1C8.7 | ↓ | OS | poor | N/E * | |
| RP11-21L19.1 | ↓ | OS | poor | N/E * | |
| RP11-503C24.1 | ↓ | OS | poor | N/E * | |
| RP11536I6.2 | ↓ | OS | poor | N/E * | |
| RP11-63A11.1 | ↓ | OS | poor | N/E * | |
| Zuo et al., 2018 [135] | AC003092.1 | ↑ | OS | poor | N/E * |
| AC079160.1 | ↑ | OS | poor | N/E * | |
| COL18A1-AS1 | ↓ | OS | poor | N/E * | |
| LINC00520 | ↑ | OS | poor | N/E * | |
| LINC02154 | ↑ | OS | poor | N/E * | |
| SLC7A11-AS1 | ↑ | OS | poor | N/E * | |
| chromophobe RCC | |||||
| He et al., 2016 [136] | COL18A1-AS1 | ↓ | OS | Poor | N/E |
| BRE-AS1 | ↓ | OS | Poor | N/E | |
| SNHG7 | ↓ | OS | Poor | N/E | |
| TMEM51-AS1 | ↓ | OS | Poor | N/E | |
| C21orf62-AS1 | ↓ | OS | Poor | N/E | |
| LINC00336 | ↓ | OS | Poor | N/E | |
| LINC00882 | ↑ | OS | poor | N/E |
Abbreviations: RCC—renal cell carcinoma; OS—overall survival; N/E—not evaluated; no multivariate analysis conducted. * Combined prognostic indices proved as independent biomarkers.